HOME >> BIOLOGY >> NEWS
New strategy rapidly identifies cancer targets

In a step toward personalized medicine, Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. By analyzing the proteins instead of the genes inside acute myeloid leukemia (AML) cells, the researchers have dramatically reduced the time it takes to zero in on molecular abnormalities that might be vulnerable to specific drug treatments.

"This approach gives us a way to figure out what's driving the growth of a cancer in an individual patient and ultimately match that patient with the right drug," said Druker, who is based at the Oregon Health & Science University in Portland. Druker's team collaborated on the research, which was published in the July 17, 2006, issue of the journal Cancer Cell, with scientists in the lab of D. Gary Gilliland, an HHMI investigator at Brigham and Women's Hospital, as well as researchers at the Portland VA Medical Center, Cell Signaling Technology, the University of Chicago, and Yale University.

Traditionally, cancer-gene hunters have scanned the genome looking for mutations that trigger out-of-control cell growth. Druker tried this approach, but found it wanting. "We were doing some high-throughput DNA sequencing, and we weren't really finding much," he said.

Instead, the team added tools from the burgeoning field of proteomics, the study of proteins. "We decided this more functional assay would get us to the disease-causing genes more rapidly," said Druker, who has been studying a group of cell-signaling proteins called tyrosine kinases for 20 years.

Tyrosine kinases play a key role in many cancers. In healthy cells, they help form a chain of signals that prompt normal cell growth and division. Sometimes, though, a tyrosine kinase gets stuck in an "on" position, driving out-of-control cell division and, ultimately, cancer. This potentially devastating kinase act
'"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
16-Jul-2006


Page: 1 2 3

Related biology news :

1. New strategy for treating allergic disorders
2. Does EPA have an adequate strategy to oversee nanotechnologies?
3. High blood pressure medication strategy proves effective in Hispanic women
4. Rutgers: GM/GMO/Biotech crop containment strategy
5. Scientists identify new strategy for preventing acute and chronic brain disease
6. International risk research strategy and funding needed for nanotech safety
7. Study shows metabolic strategy of stressed cell
8. Trojan horse strategy defeats drug-resistant bacteria
9. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
10. Drug strategy makes cancer genes get lost in translation
11. Researchers develop new strategy for the treatment of CML

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... February 11, 2020 , ... The ... medical device accelerator in Port Covington, Baltimore. The newly formed company is developing ... addressed to manage increased demand for home dialysis treatments. The start-up company will ...
(Date:2/5/2020)... (PRWEB) , ... February 04, 2020 , ... ... Trademark Office (USPTO) issued the company a second patent related to proprietary liquid ... of Allowance compliments another patent from the USPTO issued on December 3, 2019. ...
(Date:1/29/2020)... (PRWEB) , ... January 29, 2020 , ... ... receptor and in vitro toxicology testing solutions, has announced a record earnings year ... upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, ... cloud and mobile computing, today announced the availability of neuroscience of transformational leadership ... use the latest neuroscience of leadership and change research to become great transformational ...
(Date:1/24/2020)... ... 24, 2020 , ... The impact of new medicines, procedures, ... and clinical services during the first two decades of the 21st century have ... Slone Partners celebrates its 20th anniversary this year, its evolution as a ...
(Date:1/22/2020)... ... January 20, 2020 , ... ... with WAVE Electronics, the largest independent electronics distributor in the US, to make ... Smart Home Systems with leading smart home products from a single fulfillment partner. ...
(Date:1/22/2020)... Conn. (PRWEB) , ... January 21, 2020 , ... ... (CTC) liquid biopsy from a simple blood draw, today announced the sale of the ... Health. The Rare Scope will be used in clinical cancer research. , “The RareScope ...
Breaking Biology Technology:
Cached News: